Lihong Chen
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 5
- Cancer, Lipids, and Metabolism 5
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Glycosylation and Glycoproteins Research 3
- Physiology top 10%
- Toxicology top 10%
-
- Cancer Mechanisms and Therapy 4
-
- Radiopharmaceutical Chemistry and Applications 3
Lihong Chen
50 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 297
- Oncology 478
- Molecular Biology 1.1k
- Physiology 245
- Toxicology 29
Countries citing papers authored by Lihong Chen
This map shows the geographic impact of Lihong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Chen more than expected).
Fields of papers citing papers by Lihong Chen
This network shows the impact of papers produced by Lihong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Chen. The network helps show where Lihong Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lihong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 20 | |
| 2 | 2023 | 32 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 10 | |
| 7 | 2020 | 14 | |
| 8 | 2020 | 20 | |
| 9 | 2018 | 33 | |
| 10 | 2017 | 9 | |
| 11 | 2016 | 33 | |
| 12 | Current trends in PGE2 targeting for anti-inflammatory therapy. | 2016 | 5 |
| 13 | 2015 | 8 | |
| 14 | 2012 | 56 | |
| 15 | 2009 | 45 | |
| 16 | 2006 | 1 | |
| 17 | 2005 | 202 | |
| 18 | 2003 | 354 | |
| 19 | 2000 | 72 | |
| 20 | 1998 | 61 |
About Lihong Chen
Lihong Chen is a scholar working on Cancer Research, Molecular Biology and Physiology, having authored 50 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (5 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers), Cancer Mechanisms and Therapy (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Cancer Research (297 citations), Oncology (478 citations) and Molecular Biology (1.1k citations). Lihong Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include William S. Lane, Yu Pan, Daniele M. Gilkes, Jiandong Chen, Michael Ristow, Andrew W. Norris, Alison C. Jozsi, Laurie J. Goodyear, C. Ronald Kahn and Michael F. Hirshman. Their work appears in journals such as Advanced Materials, Journal of Clinical Investigation and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.